Washington Vertex Pharmaceuticals

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

FDA approves painkiller designed to eliminate the risk of addiction associated with opioids

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

CNBC on MSN · 11h

FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.

MarketWatch · 32m

Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.

14hon MSN

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX)’s Suzetrigine: ‘I Don’t See A Lot Of Upside Because That Was The Drug Of The Future For Vertex’

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

NBC News on MSN12d

'Will it really work?': Young sickle cell patient among the first to start new gene therapy

Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

The Motley Fool5d

Is Vertex Pharmaceuticals Stock a Buy in 2025?

Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

Trending now